Members highlight
Meet Our Members: Amiel D. Aviman
Co-Founder and Managing Partner, Genesis Business Humanity
Editor’s Note: This is a series by Genesis Business Humanity spotlighting the people behind Genesis. Those who make us who we are and are instrumental to all our successes and the impact we have made.
Amiel D. Aviman graduated from Ben Gurion University at the age of fifteen with dual degrees in Sciences and Business and Marketing. That detail tells you most of what you need to know about the kind of person who would go on to co-found Genesis Business Humanity. He was never going to do one thing at a time, and he was never going to wait for the conventional timeline to tell him when he was ready.
Over the three decades that followed, Amiel built and sold companies across telecom, wireless networking, cloud infrastructure, SaaS, fintech, digital media, semiconductors, and precision agriculture. As a founder, investor, CEO, Chairman, and advisor, he drove more than $2 billion in cumulative sales. For twenty of those years, he was a pioneer in the global telecom market, building businesses in a sector where the technology moved fast and the relationships moved faster. The common thread across all of it was the same: find a market that matters, build something real inside it, and bring the right people together to make it work.
Genesis came from a realization that the most valuable thing Amiel had built over those thirty years was not any single company. It was the network around it. The investors, the founders, the operators, the advisors, the people who had been in enough rooms together to trust each other when it mattered. He saw that network as something worth formalizing, not as a Rolodex but as a living community where business relationships and a shared sense of purpose could exist in the same room. That is what Genesis became.
Today, alongside co-founder and Managing Partner Ranny Yarom, Amiel leads every layer of the Genesis operation. He oversees the Star of Genesis investment platform, where Israeli-founded companies present directly to the membership. He runs due diligence sessions with portfolio companies. He personally connects founders with the American investors, distribution partners, and advisors they need to enter the U.S. market. He helped launch Genesis MedTech to give Israeli medical device companies a structured commercial pathway into American healthcare. He helped build Genesis Digital to provide AI-powered marketing and branding to companies that need to reposition for an American audience. When a portfolio company needs an introduction, a strategic conversation, or a direct line to someone who can move things forward, that call usually goes through Amiel. But if you ask the people closest to Genesis what defines Ameil, the business record is usually not the first thing they mention. What comes up is the philanthropy. Amiel co-founded Genesis Friends for Life, the organization’s 501(c)(3) nonprofit, and later established Genesis Friends for Life Israel to provide direct support to orphans, widows, and families affected by the conflict. He and his wife Natasha host Shabbat dinners for Genesis members during the annual meeting. He leads the Genesis Gala, where the membership comes together to raise funds for soldiers and victims of war. These are not side projects or obligations. They are, by his own account, the reason Genesis exists at all. The name of the organization is Genesis Business Humanity, and Amiel has always insisted that the last word carries as much weight as the middle one.
One longtime colleague put it simply: Amiel is a leader who figured out earlier than most that business grows faster and lasts longer when it is focused on something beyond itself. That conviction is not something he arrived at after success. It is something he built Genesis around from the beginning, and it shapes every relationship, every investment, and every decision the organization makes today.
For prospective members and partners meeting Genesis for the first time, it helps to know who is on the other side of the table. Now you do. (copy)
Genesis is an invitation-only investment and social club with chapters in Miami, New York/New Jersey, and Los Angeles. For Israeli startups interested in the U.S. market, contact info@genesisbh.net.
Investment
From Tel Aviv to America: What Israeli Startups Need to Know Before Entering the U.S. Market
Positioning, relationships, regulatory navigation, distribution, and what it actually takes to build credibility on the other side of the Atlantic.
Most Israeli startups come to the table without leading with what American investors actually want to see. In Israel, the product demo is the pitch. In the U.S., investors evaluate the market before they evaluate the technology. They want to see validated product-market fit, evidence of traction (revenue, LOIs, pilot results), a clear regulatory pathway, and proof that the U.S. is a real operating priority, not a flag-planted Delaware entity with a virtual mailing address. A founder who walks in leading with technical specs and patent counts is likely to lose the room. The pitch needs to open with the problem, the size of the market, why now, and what measurable evidence exists that customers are already responding. The technology supports that argument. It does not replace it.
Then there is the regulatory and distribution landscape, which is where Genesis has seen the most costly missteps. Israeli medtech and healthtech companies often arrive with CE marking or Israeli regulatory approval and assume the path to U.S. commercialization is a matter of paperwork. It is not. The FDA 510(k) clearance process alone requires identifying a valid predicate device, compiling performance data, and navigating a review timeline that can stretch six months or longer. For higher-risk devices, a Pre-Market Approval demands clinical trial data, manufacturing process documentation, and potentially a panel review, with costs reaching into the millions. Genesis MedTech supports portfolio companies through this process specifically because getting it wrong is not just expensive. It sets a company back by years.
And clearance is only the beginning. Selling a medical device into the American healthcare system means navigating a buying process that has no equivalent in Israel. Hospitals do not make purchasing decisions the way Israeli clinics do. Products go through value analysis committees that evaluate clinical evidence, economic justification, GPO and IDN contract status, and compatibility with existing systems. Getting onto a GPO contract or into an IDN formulary requires enterprise-level sales execution, health system targeting, and relationships with procurement leadership that take months or years to build. Israeli founders who plan to sell directly to clinicians the way they do at home will hit a wall they did not see coming. Genesis MedTech exists in large part because this wall kept showing up. We support partners in pulling resources together under the stewardship of industry veterans with this required regulatory knowledge and relationship channel.
The cultural gap compounds all of it. Israeli business culture rewards directness: fast decisions, blunt feedback, minimal formality. American business culture is more layered. Relationships are built before deals are discussed. Trust develops through repeated contact, shared introductions, and a demonstrated commitment to showing up consistently. A founder who flies into New York with a week of meetings expecting signed agreements by Friday will usually leave confused about why every conversation was warm but nothing moved forward. In America, a warm reception is the starting line, not the finish. The Star of Genesis platform was built around this reality. When an Israeli company presents to the Genesis membership, it enters a room of accomplished American investors and business leaders who already understand the Israel-U.S. corridor. The introductions that follow are not networking favors. They are real connections to capital, distribution, and commercial partnerships.
The U.S. market can be genuinely lucrative as an expansion step to overseas success, but the founders who make this crossing successfully all figure out the same thing early on: the American market is not a bigger version of the local one. It has its own regulatory gatekeepers, its own distribution infrastructure, its own expectations around traction and credibility, and its own pace for building trust. The ones who invest in understanding those systems, and who find the right partners to navigate them, are the ones who build something lasting here. Genesis has helped Israeli companies do this for years. For founders building something worth bringing to the American economy and looking for a guiding hand, the conversation is always open.
Genesis is an invitation-only investment and social club with chapters in Miami, New York/New Jersey, and Los Angeles. For Israeli startups interested in the U.S. market, contact info@genesisbh.net.